Literature DB >> 17894370

A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations.

Gabriella Santangelo1, Luigi Trojano, Carmine Vitale, Marta Ianniciello, Marianna Amboni, Dario Grossi, Paolo Barone.   

Abstract

The aim of this work was to determine the progression of cognitive impairment in Parkinson's disease (PD) patients with or without hallucinations. Two years after the first assessment, 36 PD patients were re-evaluated on standardized neuropsychological tests, including the Frontal Assessment Battery (FAB), and on rating scales for overall cognitive functioning, functional autonomy, behavioral disorders. Nine patients had hallucinations at baseline and endpoint assessments; 12 patients developed hallucinations during the follow-up; and 15 patients were hallucination-free throughout the study. Cognitive performance significantly declined in all three groups, but at endpoint assessment PD hallucinators scored significantly lower than nonhallucinators on phonological and semantic fluency tasks, immediate free recall and the go/no-go FAB subtest; moreover, they showed more severe apathy than nonhallucinators. Reduced phonological fluency at baseline (odds ratio [OR], 13.5; 95% CI: 1.34-135.98, P = 0.027) was the only independent predictor of onset of hallucinations after 2 years, whereas hallucinations (OR, 10.1; 95% CI: 1.94-51.54, P = 0.006) and poor phonological fluency (OR, 6.1; 95% CI: 1.04-35.03, P = 0.045) independently predicted development of diffuse cognitive impairment. We concluded that reduced verbal fluency scores may predict the onset of hallucinations, while hallucinations and poor phonological fluency may predict development of dementia in PD patients.

Entities:  

Mesh:

Year:  2007        PMID: 17894370     DOI: 10.1002/mds.21746

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  26 in total

1.  Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients.

Authors:  Roberto Erro; Gabriella Santangelo; Marina Picillo; Carmine Vitale; Marianna Amboni; Katia Longo; Angela Costagliola; Maria Teresa Pellecchia; Roberto Allocca; Anna De Rosa; Giuseppe De Michele; Lucio Santoro; Paolo Barone
Journal:  J Neurol       Date:  2012-02-07       Impact factor: 4.849

Review 2.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

3.  Dream features in the early stages of Parkinson's disease.

Authors:  Paulo Bugalho; Teresa Paiva
Journal:  J Neural Transm (Vienna)       Date:  2011-06-30       Impact factor: 3.575

Review 4.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

5.  Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Authors:  Daniel Weintraub; Nicole Dietz; John E Duda; David A Wolk; Jimit Doshi; Sharon X Xie; Christos Davatzikos; Christopher M Clark; Andrew Siderowf
Journal:  Brain       Date:  2011-11-21       Impact factor: 13.501

6.  Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders.

Authors:  Roberto Marconi; Angelo Antonini; Paolo Barone; Carlo Colosimo; Tania P Avarello; Edo Bottacchi; Antonino Cannas; Maria G Ceravolo; Roberto Ceravolo; Giulio Cicarelli; Rosa M Gaglio; Luisa Giglia; Francesco Iemolo; Michela Manfredi; Giuseppe Meco; Alessandra Nicoletti; Massimo Pederzoli; Alfredo Petrone; Antonio Pisani; Francesco E Pontieri; Rocco Quatrale; Silvia Ramat; Rossana Scala; Giampiero Volpe; Salvatore Zappulla; Anna Rita Bentivoglio; Fabrizio Stocchi; Giorgio Trianni; Paolo Del Dotto; Danilo De Gaspari; Lucia Grasso; Francesca Morgante; Gabriella Santangelo; Giovanni Fabbrini; Letterio Morgante
Journal:  Neurol Sci       Date:  2011-11-03       Impact factor: 3.307

7.  Prominent psychiatric symptoms in patients with Parkinson's disease and concomitant argyrophilic grain disease.

Authors:  O Grau-Rivera; E Gelpi; M J Rey; F Valldeoriola; E Tolosa; Y Compta; M J Martí
Journal:  J Neurol       Date:  2013-09-18       Impact factor: 4.849

8.  Hallucinations and Development of Dementia in Parkinson's Disease.

Authors:  Wojciech Gryc; Kathryn A Roberts; Cyrus P Zabetian; Daniel Weintraub; John Q Trojanowski; Joseph F Quinn; Amie L Hiller; Kathryn A Chung; Kathleen L Poston; Laurice Yang; Shu-Ching Hu; Karen L Edwards; Thomas J Montine; Brenna A Cholerton
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 9.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

10.  Cognition in multiple system atrophy: neuropsychological profile and interaction with mood.

Authors:  Meirav Balas; Yacov Balash; Nir Giladi; Tanya Gurevich
Journal:  J Neural Transm (Vienna)       Date:  2010-01-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.